ISO/TC 194
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 73582 | ISO/TS 37137-1:2021 | Biological evaluation of absorbable medical devices — Part 1: General requirements | Standarts spēkā |
| 83916 | ISO/TS 11796:2023 | Biological evaluation of medical devices — Requirements for interlaboratory studies to demonstrate the applicability of validated in vitro methods to assess the skin sensitization of medical devices | Standarts spēkā |
| 22693 | ISO 10993-14:2001 | Biological evaluation of medical devices — Part 14: Identification and quantification of degradation products from ceramics | Standarts spēkā |
| 36406 | ISO 10993-5:2009 | Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity | Standarts spēkā |
| 61089 | ISO 10993-6:2016 | Biological evaluation of medical devices — Part 6: Tests for local effects after implantation | Standarts spēkā |
| 63448 | ISO 10993-4:2017 | Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood | Standarts spēkā |
| 75323 | ISO 10993-17:2023 | Biological evaluation of medical devices — Part 17: Toxicological risk assessment of medical device constituents | Standarts spēkā |
| 55614 | ISO 10993-3:2014 | Biological evaluation of medical devices — Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity | Standarts spēkā |
| 86862 | ISO 10993-4:2017/Amd 1:2025 | Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood — Amendment 1 | Standarts spēkā |
| 84512 | ISO 10993-1:2025 | Biological evaluation of medical devices — Part 1: Requirements and general principles for the evaluation of biological safety within a risk management process | Standarts spēkā |
Displaying 1-10 of 156 results.